Sonoma PharmaceuticalsSNOA
13F holders, Q2 2026 (June 30)14holders −3
3new positions
6sold out
1famous investor
$1.23avg. 13F price*
At the end of Q2 2026, 14 institutions reported holding Sonoma Pharmaceuticals Inc. (SNOA) in their 13F filings, down 3 from Q1 2026. 3 opened new positions and 6 sold out. The largest holders were Renaissance Technologies ($50K), Geode Capital Management, LLC ($33K) and Vanguard Capital Management LLC ($23K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Sonoma Pharmaceuticals Inc.
- CUSIP
- 83558L303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $50K |
| Exits | 6 | $32K |
All 13F filers, Q1 2026 → Q2 2026: 55,590 shares bought and 14,824 shares sold, net +40,766 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Renaissance Technologies | 0.00% | New | 40,468 | $50K |
| Geode Capital Management, LLC | 0.00% | Add +34.3% | 26,787 | $33K |
| Vanguard Capital Management LLC | 0.00% | No change | 18,787 | $23K |
| McKinley Carter Wealth Services, Inc. | 0.00% | No change | 11,193 | $14K |
| UBS Group AG | 0.00% | Add +130033.3% | 7,808 | $10K |
| Global Retirement Partners, LLC | 0.00% | — | 2,548 | $3K |
| Morgan Stanley | 0.00% | Reduce -0.2% | 2,000 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 500 | $615 |
| Barclays PLC | 0.00% | New | 459 | $565 |
| BlackRock, Inc. | 0.00% | No change | 113 | $139 |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 100 | $123 |
| Harbour Investments, Inc. | 0.00% | New | 15 | $18 |
| Quaker Wealth Management, LLC | 0.00% | No change | 3 | $4 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is SNOA's weight in each manager's 13F, not the share of Sonoma Pharmaceuticals Inc. the manager owns.